Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E04-12-1119 on March 30, 2005

Vol. 16, Issue 6, 3028-3039, June 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E04-12-1119v1
16/6/3028    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ortega, N.
Right arrow Articles by Werb, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortega, N.
Right arrow Articles by Werb, Z.

Galectin-3 Is a Downstream Regulator of Matrix Metalloproteinase-9 Function during Endochondral Bone Formation

Nathalie Ortega * {dagger}, Danielle J. Behonick *, Céline Colnot {ddagger}, Douglas N.W. Cooper * §, and Zena Werb *

* Department of Anatomy, University of California–San Francisco, San Francisco, CA 94143; {ddagger} Department of Orthopaedic Surgery, University of California–San Francisco, San Francisco, CA 94143; and § Department of Langley Porter Psychiatric Institute, University of California–San Francisco, San Francisco, CA 94143

Submitted December 27, 2004; Revised March 16, 2005; Accepted March 23, 2005
Monitoring Editor: Jean Schwarzbauer

Endochondral bone formation is characterized by the progressive replacement of a cartilage anlagen by bone at the growth plate with a tight balance between the rates of chondrocyte proliferation, differentiation, and cell death. Deficiency of matrix metalloproteinase-9 (MMP-9) leads to an accumulation of late hypertrophic chondrocytes. We found that galectin-3, an in vitro substrate of MMP-9, accumulates in the late hypertrophic chondrocytes and their surrounding extracellular matrix in the expanded hypertrophic cartilage zone. Treatment of wild-type embryonic metatarsals in culture with full-length galectin-3, but not galectin-3 cleaved by MMP-9, mimicked the embryonic phenotype of Mmp-9 null mice, with an increased hypertrophic zone and decreased osteoclast recruitment. These results indicate that extracellular galectin-3 could be an endogenous substrate of MMP-9 that acts downstream to regulate hypertrophic chondrocyte death and osteoclast recruitment during endochondral bone formation. Thus, the disruption of growth plate homeostasis in Mmp-9 null mice links galectin-3 and MMP-9 in the regulation of the clearance of late chondrocytes through regulation of their terminal differentiation.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E04-12-1119) on March 30, 2005.

Abbreviations used: Col2, collagen type II; Col10, collagen type X; CTGF, connective tissue growth factor; ECM, extracellular matrix; HC, hypertrophic chondrocyte(s); MMP, matrix metalloproteinase; PECAM, platelet endothelial cell adhesion molecule; TRAP, tartrate-resistant acidic phosphatase; TG2, tissue transglutaminase; MT1-MMP, membrane type 1 matrix metalloproteinase; VEGF, vascular endothelial growth factor.

{dagger} Present address: IPBS, CNRS UMR 5089, Laboratoire de Biologie Vasculaire, 205 route de Narbonne, 31077 Toulouse Cedex, France.

Address correspondence to: Zena Werb (zena{at}itsa.ucsf.edu).




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. A. Dean, G. S. Butler, Y. Hamma-Kourbali, J. Delbe, D. R. Brigstock, J. Courty, and C. M. Overall
Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 Proteolysis
Mol. Cell. Biol., December 15, 2007; 27(24): 8454 - 8465.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. Welm, J. B. Sneddon, C. Taylor, D. S. A. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans
PNAS, May 1, 2007; 104(18): 7570 - 7575.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Miyanishi, N. Nishi, H. Abe, Y. Kashio, R. Shinonaga, S.-i. Nakakita, W. Sumiyoshi, A. Yamauchi, T. Nakamura, M. Hirashima, et al.
Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family
Glycobiology, April 1, 2007; 17(4): 423 - 432.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Nagase, R. Visse, and G. Murphy
Structure and function of matrix metalloproteinases and TIMPs
Cardiovasc Res, February 15, 2006; 69(3): 562 - 573.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
A. P. Hall, F. R. Westwood, and P. F. Wadsworth
Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate
Toxicol Pathol, February 1, 2006; 34(2): 131 - 147.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.